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Introduction
Septic shock is a major health care problem which affects
between 20-30 million people per year worldwide [1].
Objectives
The objective of this study was to analyse the burden of
septic shock in 2012 for England, Wales and Northern
Ireland.
Methods
We analyzed length of stay, survival and organ support
of adult septic shock patient admitted to general critical
care units. Septic shock was defined as severe sepsis
including the presence of cardiovascular organ dysfunc-
tion (from cardiovascular SOFA Score of 2, 3 or 4). Phy-
siological definitions were matched as closely as possible
to those used in the PROWESS trial [2].
These data derive from the Case Mix Programme
Database. The Case Mix Programme is the national,
comparative audit of patient outcomes from adult criti-
cal care coordinated by the Intensive Care National
Audit & Research Centre (ICNARC). These analyses are
based on data for 136,880 admissions to 205 adult,
general critical care units based in NHS hospitals
geographically spread across England, Wales and Northern
Ireland. For more information on the representativeness
and quality of these data, please contact ICNARC.
Results
Tables 1 and 2.
Conclusions
It is evident that patients who develop septic shock pose
a heavy burden to the UK society, as well as to the NHS
hospitals. One in every six patient admitted to a critical
care unit is diagnosed with septic shock. Nearly 40 per-
cent ultimately die while staying at the hospital, of
which close to 30 percent die during CCU stay. These
patients also require substantial renal and respiratory
support, as well as total hospital stays of up to a month.
Septic shock is a very burdensome and costly illness and
every effort should be made to reduce this burden to
the patients, hospitals and society.
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Table 1 Case mix and mortality of admissions.
Number of admissions with septic shock (%) 22,081 (16.1)
Number of patients with septic shock 20,549
Age in years (mean/median) 64.0/67
Gender, percent males 52.6
Total hospital mortality, deaths (%) 7724 (37.6)
- Mortality during first CCU admission, deaths (%)* 5772 (28.1)
- Post first CCU in-hospital mortality, deaths (%) 1952 (9.5)
* Including 1532 re-admissions to CCU, total CCU mortality is 6100 deaths
(29.7%).
Table 2 Length of hospital stay and organ support in 2012.
Critical care unit average length of stay in days (median) -
All
7.6 (4.1)
- Unit survivors 8.2 (4.7)
- Unit non-survivors 5.9 (2.4)
Post-unit average length of stay in days (median) - All 23.3
(31.4)
Average number of organs supported (median) 2.1 (2)
- Percentage receiving continuous renal support 20.1
- Days of renal support (mean/median) 5.4/3
- Percentage receiving advanced respiratory support 62.5
- Days of advanced respiratory support (mean/median) 7.7/4
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